Ascensia has an international alliance with Medtronic to develop and market innovative diabetes management solutions for patients worldwide, which has been in place since 2007 . As part of the current agreement, Ascensia exclusively co-develops and supplies linking blood glucose meters from the CONTOUR^®NEXT and CONTOUR^®PLUS portfolios that are wirelessly compatible to communicate with Medtronic’s integrated insulin pump and continuous glucose monitoring systems. These meters seamless integrate with the MiniMed^® family of insulin pump systems, transmitting blood glucose results wirelessly directly to the insulin pump. These blood glucose monitoring systems are exclusively packaged and shipped as part of an integrated system with the MiniMed^® Paradigm and 6 Series pump systems (including the MiniMed^® 630G and MiniMed^® 670G).

Ascensia has a strategic alliance with Insulet Corporation for the development and commercialization of the Insulet Omnipod DASH™ Personal Diabetes Manager (DASH™ PDM). The global development agreement was first announced in June 2017 and the global commercial agreement was announced in January 2018. Under the terms of the agreement, the CONTOUR^®NEXT ONE blood glucose monitoring systems will connect via Bluetooth Low Energy to the DASH™ PDM, which has recently been approved by the FDA. The highly accurate CONTOUR^®NEXT ONE has been optimized for use with the Omnipod DASH System and is the only meter designed to wirelessly transmit readings directly to the PDM.

Ascensia has entered into a commercial agreement with Dexcom, Inc. to provide the CONTOUR^®NEXT ONE blood glucose monitoring system for inclusion in the bundle of supplies that is provided with the Dexcom G5^® continuous glucose monitoring system to Medicare patients with diabetes in the US. This agreement is only applicable in the United States.

Ascensia and Glooko has a global technology partnership that integrates Glooko’s Diabetes Data Management Platform with Ascensia’s CONTOUR^®NEXT ONE and CONTOUR^®PLUS ONE systems. The integration allows blood glucose data from the CONTOUR^®NEXT ONE and CONTOUR^®PLUS ONE meters to be accessed by Glooko's Mobile App and Clinic Data Upload products directly from the meters via Bluetooth^® connectivity. Data can be accessed by patients via Glooko’s Mobile App and by HCPs via Glooko’s Clinic Data Upload products.

Ascensia and Voluntis have agreed a global technology partnership. Under the terms of the agreement, the CONTOUR^®NEXT ONE and CONTOUR^®PLUS ONE meters will connect via Bluetooth to the Insulia^® Diabetes Management Companion that has been developed by Voluntis. Insulia^® will use readings from the CONTOUR^®NEXT ONE or CONTOUR^®PLUS ONE meters to calculate basal insulin dosing for people with type 2 diabetes.

Ascensia and Quattro Folia have entered into a regional technology partnership. Under the terms of the agreement, the CONTOUR^®NEXT ONE and CONTOUR^®PLUS ONE meters will connect via Bluetooth to the Balansio Mobile App that has been developed by Quattro Folia. The Balansio Mobile App includes a bolus insulin calculator for type 1 diabetes patients, and will use readings from the CONTOUR^®NEXT ONE or CONTOUR^®PLUS ONE meters to calculate bolus insulin dosing. Balansio is currently available in Finland, Sweden and UK.

Ascensia has signed an agreement with myDiabby Healthcare platform to connect to the CONTOUR^®NEXT ONE blood glucose monitoring system via Bluetooth. MyDiabby Healthcare is an online platform for the follow up of people with gestational, type 1 or type 2 diabetes, which is available in France, Belgium, Switzerland and Luxembourg, and is used by more than 30% of French hospitals.

Ascensia and Health2Sync have entered into a collaboration that aims to improve diabetes care by bringing an integrated digital management solution to patients in Asia. As part of this collaboration, the companies have created a combined offering for people with diabetes that is comprised of the CONTOUR^®PLUS or CONTOUR^®TS blood glucose monitoring systems from Ascensia, the Health2Sync app and a loyalty program for users, known as the Ascensia Customer Care Program.